<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Sani MU</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>The relationship between N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and galectin-3 and outcomes has not been studied in African patients with acute heart failure (AHF). The current analysis sought to describe the association between plasma levels of NT-pro-BNP and galectin-3 and cardiovascular (CV) death or heart failure (HF) hospitalization, as well as their associations with symptoms and echocardiography markers of left and right ventricular remodelling among AHF patientsv in sub-Saharan Africa.&lt;h4>Methods and results&lt;/h4>In a subset of 80 patients with complete data in a study assessing the effects of hydralazine and nitrates in patients with AHF (BAHEF trial; NCT01822808), NT-pro-BNP and galectin-3 analyses were performed, and the association with various charac</pubmed_abstract><journal>ESC heart failure</journal><pagination>74-84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7835570</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trial.</pubmed_title><pmcid>PMC7835570</pmcid><pubmed_authors>Damasceno A</pubmed_authors><pubmed_authors>Mayosi BM</pubmed_authors><pubmed_authors>Edwards C</pubmed_authors><pubmed_authors>Azibani F</pubmed_authors><pubmed_authors>Sani MU</pubmed_authors><pubmed_authors>Cotter G</pubmed_authors><pubmed_authors>Arif G</pubmed_authors><pubmed_authors>Davison BA</pubmed_authors><pubmed_authors>Adam T</pubmed_authors><pubmed_authors>Sliwa K</pubmed_authors><pubmed_authors>Jessen N</pubmed_authors></additional><is_claimable>false</is_claimable><name>N-terminal pro BNP and galectin-3 are prognostic biomarkers of acute heart failure in sub-Saharan Africa: lessons from the BAHEF trial.</name><description>&lt;h4>Aims&lt;/h4>The relationship between N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and galectin-3 and outcomes has not been studied in African patients with acute heart failure (AHF). The current analysis sought to describe the association between plasma levels of NT-pro-BNP and galectin-3 and cardiovascular (CV) death or heart failure (HF) hospitalization, as well as their associations with symptoms and echocardiography markers of left and right ventricular remodelling among AHF patientsv in sub-Saharan Africa.&lt;h4>Methods and results&lt;/h4>In a subset of 80 patients with complete data in a study assessing the effects of hydralazine and nitrates in patients with AHF (BAHEF trial; NCT01822808), NT-pro-BNP and galectin-3 analyses were performed, and the association with various charac</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-26T02:25:54.582Z</modification><creation>2021-02-21T05:28:48Z</creation></dates><accession>S-EPMC7835570</accession><cross_references><pubmed>33247624</pubmed><doi>10.1002/ehf2.13032</doi></cross_references></HashMap>